Pila Pharma aktieemission - næste skridt mod fedmepille
-
Det dansk-svenske biotekselskab Pila Pharma satser benhårdt på en fedmepille baseret på en såkaldt chili-receptor. Derfor gennemfører selskabet en aktieemission på 20 mio. SEK og optioner, så de kan komme videre på rejsen med prekliniske studier. En emission, som ganske usædvanligt er fuldstændig forhåndsgaranteret. Hør mere i denne video, hvor Helge Larsen har CEO Gustav Gram i studiet, og læs mere om emissionen her https://pilapharma.com/
Disclaimer: Denne video er ikke en opfordring til køb eller salg af aktier.
-
XEN-D0501 er et SMD (small molecule drug).
https://en.wikipedia.org/wiki/XEN-D0501 -
Overtegnet med 293%
PILA PHARMA announces the outcome of its oversubscribed rights issue and resolves on a directed issue for over-allotment.
PILA PHARMA announces the outcome of its oversubscribed rights issue and resolves on a directed issue for over-allotment - PILA PHARMA | beQuoted Nyheter
THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEE...
beQuoted Nyheter (news.bequoted.com)
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind